A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1999
12/14/1999	US6001563 Detecting a substance which sensitizes cell to therapeutic agent; contacting transfected cell with drug in vitro, determining resistance to drug, detecting sensitizer; for reversing drug resistance in cells; anticarcinogenic agents
12/14/1999	US6001395 Polymeric lamellar substrate particles for drug delivery
12/14/1999	US6001386 For treatment of uveitis eye disease
12/14/1999	US6001365 Conjugating empty human class i molecules surface-expressed on drosophila cells to a toxin in vitro; contacting said molecules with antigenic peptides derived from said transplanted tissue to load said conjugates with peptides
12/14/1999	US6001363 Eimeria protein with immunogenic properties; dna encoding this protein can be used for the preparation of a vector vaccine against coccidiosis
12/14/1999	US6001362 Treatment of an individual in need of response regulator polypeptide comprising administering to the individual a therapeutically effective amount of a polypeptide comprising given amino acid sequence
12/14/1999	US6001361 For the prevention, treatment and diagnosis of mycobacterial infection, together with adjuvants for use in vaccines or immunotherapy of infectious diseases and cancers; for preventing, treating and detecting tuberculosis
12/14/1999	US6001358 Useful for treatment of autoimmune diseases
12/14/1999	US6001357 Method of enhancing wound healing with anti-IL-5 antibody
12/14/1999	US6001355 Dosage units comprising a human tissue plasminogen activator (tpa) and pro-tpa (a precursor of tpa) in specific ratios in compatible medium; pro-tpa has a higher affinity for fibrin and better selectivity than tpa
12/14/1999	US6001354 GRB2 associating polypeptides and nucleic acids encoding therefor
12/14/1999	US6001353 20α-alpha-hydroxy steroid dehydrogenase related material and methods
12/14/1999	US6001350 Genetic modification of endothelial cells
12/14/1999	US6001347 Organic acid compound of given structure having an aromatic amide group, a methoxy group in the ortho position on the aromatic ring, and a lipophilic chain terminated with a carboxylic acid is useful as a nontoxic carrier
12/14/1999	US6001336 Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof
12/14/1999	US6001329 Radiolabeled fusion toxins for cancer therapy
12/14/1999	US6001259 Preparation of autologous plasma and fibrin gel
12/14/1999	CA2186526C Method and product for regulating cell responsiveness to external signals
12/14/1999	CA2181150C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
12/14/1999	CA2172137C Surface loop structural analogues of fibroblast growth factors
12/14/1999	CA2155024C Genetic modification of neural stem cells
12/14/1999	CA2135642C Tat-derived transport polypeptides
12/14/1999	CA2095642C Adhesion receptors for pathogenic or opportunistic microorganisms
12/14/1999	CA2092720C Macrophage activating factor from vitamin d binding protein
12/14/1999	CA2084186C Purification of human interleukin-4 secreted from a escherichia coli mutant
12/14/1999	CA2081028C Cd2 binding domain of lymphocyte function associated antigen 3
12/14/1999	CA2065150C Inhibitors of thrombin
12/14/1999	CA2046830C Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
12/14/1999	CA2033176C Growth hormone fusion proteins
12/14/1999	CA2030810C Grf analogs viia
12/14/1999	CA2014971C Inhibitive agent against activity of alpha-amylase
12/14/1999	CA2014590C Novel peptides, and antidementia agents containing the same
12/14/1999	CA1340852C Process for purifying primate gm-csf protein
12/14/1999	CA1340850C Nisin compositions for use as enhanced, broad range bactericides
12/09/1999	WO1999063114A1 Antisense oligonucleotide modulation of human thymidylate synthase expression
12/09/1999	WO1999063101A2 Transfected cells and methods for treating diabetes
12/09/1999	WO1999063097A2 Caspase-9 deficient animals and the use thereof
12/09/1999	WO1999063094A2 Nucleotide and protein sequences of gpr1 and methods based thereon
12/09/1999	WO1999063090A2 Protease inhibitor peptides
12/09/1999	WO1999063087A1 G-protein coupled receptor, named 2871 receptor
12/09/1999	WO1999063084A1 T cell antigen receptor sequences specific to arthrosis deformans
12/09/1999	WO1999063080A1 HUMAN HOMOLOGUE OF UNC-53 PROTEIN OF $i(C. ELEGANS)
12/09/1999	WO1999063079A1 Endometriosis-associated gene
12/09/1999	WO1999063071A2 Method for triggering apoptosis in cells
12/09/1999	WO1999063070A1 Human protein c polypeptide
12/09/1999	WO1999063067A1 Carbamoyl phosphate synthase homolog
12/09/1999	WO1999063066A2 Amino-modified ribozymes
12/09/1999	WO1999063065A1 A human hematopoietic cell derived rna cyclase (hrdc) gene (cbuaea12)
12/09/1999	WO1999063063A1 Cellular proteins which mediate herpesvirus entry
12/09/1999	WO1999062956A1 Angiopoietin related gene sequence scarface 3
12/09/1999	WO1999062955A1 Method of designing agonists and antagonists to egf receptor family
12/09/1999	WO1999062954A1 A HUMAN MAGO GENE (h-MAGO)
12/09/1999	WO1999062953A1 A human leucine zipper protein gene (bmh) (cblayd06)
12/09/1999	WO1999062949A1 A human ubiquinone oxireductase subunit ci-b17 homolog gene (cblale02)
12/09/1999	WO1999062948A1 A human ubiquinone oxireductase subunit ci-b22 homolog gene (cbnafa09)
12/09/1999	WO1999062947A1 A human ubiquinone oxireductase subunit ci-pdsw homolog gene (cblaic08)
12/09/1999	WO1999062946A1 nrdF
12/09/1999	WO1999062945A2 Peptide antigens for detection of hiv, hcv and other microbial infections
12/09/1999	WO1999062944A2 Protein oligomer compositions comprising endostatin protein and methods of using the same
12/09/1999	WO1999062943A2 Novel molecules of the aip-related protein family and uses thereof
12/09/1999	WO1999062942A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
12/09/1999	WO1999062941A2 Serpentine transmembrane antigens expressed in human cancers and uses thereof
12/09/1999	WO1999062940A2 Methods of altering cardiac cell phenotype
12/09/1999	WO1999062939A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
12/09/1999	WO1999062938A2 Polypeptides, traditionally of the human herpes virus type 8 and the diagnostic and medical application thereof
12/09/1999	WO1999062934A1 Interferon receptor hkaef92
12/09/1999	WO1999062931A2 A cell density signal protein suitable for treatment of connective tissue injuries and defects
12/09/1999	WO1999062927A1 Connective tissue growth factor-4
12/09/1999	WO1999062925A1 Angiopoietin related gene sequence scarface 1
12/09/1999	WO1999062563A2 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
12/09/1999	WO1999062562A1 Prosthetic implant and methods of use for therapeutic gene expression
12/09/1999	WO1999062561A2 Gene therapy method
12/09/1999	WO1999062558A1 Insulin supplemented infant formula
12/09/1999	WO1999062556A1 Eosinophil chemotactic factor
12/09/1999	WO1999062550A1 Pan-specific anti-allergy therapy
12/09/1999	WO1999062549A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases
12/09/1999	WO1999062548A1 Methods and compositions for diagnosing tauopathies
12/09/1999	WO1999062547A1 HUMAN MINOR VAULT PROTEIN p193
12/09/1999	WO1999062545A2 GnRH VACCINES FOR SUPPRESSING REPRODUCTIVE BEHAVIOUR IN ANIMALS
12/09/1999	WO1999062544A1 Activator protein of human acid maltase and uses thereof
12/09/1999	WO1999062543A1 Composition based on pentoxifylline and anticytokin
12/09/1999	WO1999062542A1 Recombinant human interferon beta-1a (ifn-beta-1a) formulation
12/09/1999	WO1999062541A1 Immunosuppressants containing clusterins
12/09/1999	WO1999062540A1 Use of cyclosporins in the treatment of inflammatory autoimmune diseases
12/09/1999	WO1999062539A1 Lysine containing peptides for treatment of heart disease
12/09/1999	WO1999062538A1 Alpha-keto oxadiazoles as serine protease inhibitors
12/09/1999	WO1999062537A1 Methods and agents for modulating the immune response and inflammation involving monocyte and dendritic cell membrane proteins
12/09/1999	WO1999062536A2 Pharmaceutical formulations for igf/igfbp
12/09/1999	WO1999062535A2 Receptor ligand antagonist complexes and their use in treating or preventing receptor mediated diseases
12/09/1999	WO1999062534A1 IL-6/sIL-6R COMPLEX FOR PROMOTION OF LIVER FUNCTIONS
12/09/1999	WO1999062527A1 nrdE
12/09/1999	WO1999062526A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
12/09/1999	WO1999062498A1 Spill resistant pharmaceutical compositions
12/09/1999	WO1999062494A2 Membrane-permeable inhibitor of dynamin-mediated endocytosis
12/09/1999	WO1999062483A1 Pipecolic acid derivative hair growth compositions and uses
12/09/1999	WO1999062459A2 Agents and methods for protection, treatment and repair of connective tissue
12/09/1999	WO1999054437A3 Novel molecules of the t125-related protein family and uses thereof
12/09/1999	WO1999052544A9 Regulation of ovarian maturation and function using epidermal growth factor
12/09/1999	WO1999051720A3 Methods for production of therapeutic cytokines
12/09/1999	WO1999051275A3 Mesenchymal stem cells as immunosuppressants

1 ... 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 ... 3163